Researchers from Brian Cunningham’s lab, in collaboration with researchers at Washington University, have demonstrated a new capability to detect and count individual biomolecules at low concentrations.
Researchers from Brian Cunningham’s lab, in collaboration with researchers at Washington University, have demonstrated a new capability to detect and count individual biomolecules at low concentrations.
The pivotal role of microRNA in diagnosing and monitoring cancer is well known by today’s researchers. “There have been a lot of studies in recent years linking the presence and concentration of specific microRNA sequences to clinical outcomes for people with advanced prostate cancer,” said Brian Cunningham (CGD leader/MMG), a professor of electrical and computer engineering and a program leader at the Cancer Center at Illinois.